A likely AI-generated PowerShell script mapped Active Directory after an attacker gained RDP access to a Windows Server with ...

From late April 2026 to mid-June 2026, Microsoft Defender Experts observed increased ACR Stealer activity across customer ...

AI company Anthropic announced Tuesday that it is moving its popular Claude Cowork agent to the cloud, making it accessible to users from multiple devices, and able to perform tasks even when the ...

Microsoft has observed a surge in attacks using the ACR Stealer malware to steal browser-stored passwords, authentication ...

If you are a developer and want to incorporate Microsoft Scout in your workflow, check out this guide to install and use it ...

WhatsApp will let users go by usernames instead of phone numbers, closing a longstanding privacy gap on the app used by more than three billion people. The Meta-owned platform said on Monday that it ...

SPOILER ALERT: This story contains plot details, including about the ending, from DC Studios’ “Supergirl,” now playing in theaters. It took more than five-and-a-half years, and countless hours reading ...

In a move to enhance user convenience, the Unique Identification Authority of India (UIDAI) has allowed individuals to add or update their email ID directly through the Aadhaar App, according to a ...

Anthropic goes to great lengths to prevent people in China from using its AI models, but in practice, its safeguards have often failed. Over the past year, startups, researchers, and tech enthusiasts ...

In 2026, most companies are using AI in some fashion, as companies feel pressure to keep up with competitive industry dynamics and experiment with the new technology. The stocks on this list were ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...